Literature DB >> 23617562

Cogan's syndrome associated with orbital inflammation.

Fatema Lucy Shahid1, Rita Mukherjee, Christopher Knapp.   

Abstract

Cogan's syndrome is a relatively rare inflammatory disorder presenting with a combination of ocular and vestibuloauditory symptoms. The first cases were described by David Cogan in 1945. Typically the ocular signs involve the anterior segment; however there are no descriptions of orbital inflammation associated with Cogan's syndrome. We describe such a case. A 66-year-old immunosuppressed male patient with known Cogan's syndrome presented to the eye department with right-sided proptosis, chemosis and ocular injection. Ocular motility was reduced. Other than Cogan's syndrome there were no other systemic disorders. Medical treatment included: Azathioprine 125 mg/day and low dose Tab Prednisolone 30 mg/day. A provisional diagnosis of orbital cellulitis was made and intravenous antibiotics started. Blood investigations showed raised CRP levels 475 mg/L and raised WCC (24 × 10(9)/l). An urgent CT scan of the head and orbits ruled out orbital cellulititis. The diagnosis was revised and the patient was treated for orbital inflammatory disease. Pulsed intravenous methlyprednisolone was commenced and oral steroids were increased to 60 mg/day, the Azathioprine was continued. Over the following week, the proptosis had resolved, and oral steroids were reduced back to the maintenance dose. To our knowledge this is the first description of orbital inflammatory disease associated with Cogan's syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23617562     DOI: 10.3109/01676830.2013.764324

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  3 in total

Review 1.  Cogan's syndrome and other ocular vasculitides.

Authors:  Gabriela M Espinoza; Angela Prost
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

2.  Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab.

Authors:  Kazusato Hara; Masataka Umeda; Keiko Segawa; Midori Akagi; Yushiro Endo; Tomohiro Koga; Shin-Ya Kawashiri; Kunihiro Ichinose; Hideki Nakamura; Takahiro Maeda; Atsushi Kawakami
Journal:  Intern Med       Date:  2021-10-05       Impact factor: 1.282

3.  Sudden sensorineural hearing loss in atypical Cogan's syndrome: A case report.

Authors:  José Luis Treviño González; German A Soto-Galindo; Rafael Moreno Sales; Josefina A Morales Del Ángel
Journal:  Ann Med Surg (Lond)       Date:  2018-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.